Quaker Chemical (NYSE:KWR) Price Target Lowered to $180.00 at Royal Bank of Canada

Quaker Chemical (NYSE:KWR) had its target price reduced by Royal Bank of Canada from $195.00 to $180.00 in a research report report published on Monday, Benzinga reports. They currently have an outperform rating on the specialty chemicals company’s stock.

A number of other analysts have also issued reports on KWR. StockNews.com raised Quaker Chemical from a “hold” rating to a “buy” rating in a research report on Tuesday, October 29th. Deutsche Bank Aktiengesellschaft dropped their price objective on Quaker Chemical from $190.00 to $182.00 and set a “buy” rating on the stock in a report on Monday.

Quaker Chemical Trading Down 1.2 %

Shares of Quaker Chemical stock traded down $1.87 during trading hours on Monday, reaching $158.38. 3,025 shares of the company’s stock were exchanged, compared to its average volume of 94,151. The firm has a market capitalization of $2.82 billion, a price-to-earnings ratio of 23.50, a price-to-earnings-growth ratio of 1.92 and a beta of 1.38. The company has a current ratio of 2.54, a quick ratio of 1.88 and a debt-to-equity ratio of 0.48. Quaker Chemical has a 52-week low of $151.31 and a 52-week high of $221.94. The company has a fifty day moving average of $162.71 and a 200-day moving average of $171.85.

Quaker Chemical (NYSE:KWR) last issued its quarterly earnings results on Thursday, October 31st. The specialty chemicals company reported $1.89 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.08 by ($0.19). Quaker Chemical had a return on equity of 10.10% and a net margin of 6.58%. The business had revenue of $462.27 million during the quarter, compared to analyst estimates of $469.17 million. During the same period in the previous year, the business posted $2.05 earnings per share. The firm’s quarterly revenue was down 5.8% on a year-over-year basis. Sell-side analysts forecast that Quaker Chemical will post 8.18 EPS for the current fiscal year.

Institutional Trading of Quaker Chemical

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. BNP Paribas Financial Markets grew its position in Quaker Chemical by 22.1% in the 1st quarter. BNP Paribas Financial Markets now owns 20,072 shares of the specialty chemicals company’s stock worth $4,120,000 after purchasing an additional 3,632 shares during the last quarter. Capstone Investment Advisors LLC raised its stake in Quaker Chemical by 24.3% during the 1st quarter. Capstone Investment Advisors LLC now owns 2,926 shares of the specialty chemicals company’s stock valued at $601,000 after acquiring an additional 572 shares in the last quarter. Fidelis Capital Partners LLC acquired a new position in Quaker Chemical during the 1st quarter worth $25,000. Mutual of America Capital Management LLC grew its stake in shares of Quaker Chemical by 64.1% in the first quarter. Mutual of America Capital Management LLC now owns 24,419 shares of the specialty chemicals company’s stock worth $5,012,000 after purchasing an additional 9,535 shares in the last quarter. Finally, GSA Capital Partners LLP acquired a new position in shares of Quaker Chemical during the first quarter valued at $706,000. 77.46% of the stock is currently owned by institutional investors and hedge funds.

Quaker Chemical Company Profile

Quaker Chemical Corporation, together with its subsidiaries, develops, produces, and markets various formulated specialty chemical products for a range of heavy industrial and manufacturing applications in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals.